Chris H. Takimoto, Chief Medical Officer at Forty Seven, Inc. (FTSV), sold 2,500 shares at $15.05 ($38K) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Scheduled sale ($38k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IGMS | SELL | 2024-03-15 | $54K | — | Filing → |
| IGMS | SELL | 2023-12-01 | $7K | — | Filing → |
| IGMS | SELL | 2023-05-25 | $15K | — | Filing → |